Gleevec
Gleevec is a oncology medication containing Imatinib, available as 100/400mg tablets.
Details
- Conditions
- Chronic myeloid leukaemia · Gastrointestinal stromal tumour
- Alternative Name
- Glivec
- Therapeutic Class
- Tyrosine Kinase Inhibitor
- Pharmacological Class
- Tyrosine Kinase Inhibitor
- Minor Side Effects
- nausea, muscle cramps, oedema, fatigue
- Moderate Side Effects
- diarrhoea, headache, neutropaenia
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Prescription medicine
- Originator
- Novartis
- Onset Time
- 2–4 hours
- Duration
- 24 hours
- Storage Instructions
- Store below 30°C.
- Drug Interactions
- Ketoconazole, Warfarin, Grapefruit
- Age Restrictions
- Used in children with specific leukaemic conditions.
What you will receive
Gleevec is the originator brand name, made by Novartis. We use it here to identify the medicine only; we are not affiliated with Novartis and do not ship the original Gleevec.
- You receive a generic equivalent: the same active ingredient (Imatinib) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.